Randomized Study of Osseotite Certain Tapered Prevails vs. Osseotite Certain Tapered
Bolivar
A Prospective Randomized-controlled Evaluation of the Osseotite Certain Tapered Prevail Implant for the Preservation of Crestal Bone
1 other identifier
interventional
92
1 country
1
Brief Summary
This study will demonstrate the benefits of platform switching design of the Osseotite dental implant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 7, 2012
CompletedFirst Posted
Study publicly available on registry
February 9, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedMarch 28, 2022
March 1, 2022
6.1 years
February 7, 2012
March 24, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cumulative Success Rate
An implant will be considered successful if it is immobile when tested at various study time point
3 years
Secondary Outcomes (1)
Crestal Bone Regression
3 years
Study Arms (2)
Osseotite Certain Tapered Prevail
EXPERIMENTALOsseotite Certain Tapered Prevail design with platform switching feature
Osseotite Certain Tapered
ACTIVE COMPARATOROsseotite Certain Tapered implant with non-platform switching design
Interventions
Osseotite implant with platform switching feature
Osseotite implant with non-platform switching feature
Eligibility Criteria
You may qualify if:
- patients of either sex and older than 18 years of age
- patients needing at least one dental implant to treat partial edentulism
- patients physically able to tolerate surgical and restorative dental procedures
- patients agreeing to all protocol visits
You may not qualify if:
- patients with infection or severe inflammation at the intended treatment sites
- patients smoking greater than 10 cigarettes per day
- patients with uncontrolled diabetes mellitus
- patients with uncontrolled metabolic diseases
- patients who received radiation treatment to the head in the past 12 months
- patients needing bone grafting at the intended treatment sites
- patients known to be pregnant at screening visit
- patients with para-functional habits like bruxing and clenching
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ZimVielead
Study Sites (1)
Universidad Finis Terrae
Santiago, Chile
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Manuel Pavez, DDS
Universidad Finis Terrae
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 7, 2012
First Posted
February 9, 2012
Study Start
November 1, 2010
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
March 28, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share